Biomarkers offer several advantages in toxicological studies. They can provide a more accurate assessment of exposure and effect compared to traditional methods, which often rely on environmental measurements and self-reported data. Biomarkers can also help identify early biological changes before clinical symptoms appear, enabling preventive measures. Furthermore, they allow for more personalized risk assessments by considering individual variability in response to toxicants.
